Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|September 5, 2022
Drug-induced tumor-specific cytotoxicity in a whole tissue <i>ex vivo</i> model of human pancreatic ductal adenocarcinomaCarlos Fernández Moro, Arun Kumar Selvam, Mehran Ghaderi, et al.
International Journal of Cancer|September 12, 2022
Assessing the risk of cervical neoplasia in the post-HPV vaccination eraMatti Lehtinen, Ville N Pimenoff, Belinda Nedjai, et al.
International Journal of Cancer|February 6, 2019
Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)Penelope Gray, Tapio Luostarinen, Simopekka Vänskä, et al.
Plos One|July 11, 2024
Seroepidemiological assessment of the spread of SARS-CoV-2 among 25 and 28 year-old adult women in Finland between March 2020-June 2022Penelope Gray, Tiina Eriksson, Lovisa Skoglund, et al.
Preventive Medicine Reports|August 30, 2021
Differences in risk for SARS-CoV-2 infection among healthcare workersK Miriam Elfström, Jonas Blomqvist, Peter Nilsson, et al.
International Journal of Cancer|November 7, 2025
Controlled trial of cervical cancer screening frequency among human-papillomavirus-vaccinated womenMònica Ortega Llobet, Penelope Gray, Iacopo Baussano, et al.
NPJ Vaccines|August 13, 2024
Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort studyPenelope Gray, Filipe Colaço Mariz, Carina Eklund, et al.
Genome Biology|April 27, 2019
Whole-genome sequence analysis of a Pan African set of samples reveals archaic gene flow from an extinct basal population of modern humans into sub-Saharan populationsBelen Lorente-Galdos, Oscar Lao, Gerard Serra-Vidal, et al.
The Journal of Infectious Diseases|March 13, 2020
Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is AppliedSimopekka Vänskä, Tapio Luostarinen, Iacopo Baussano, et al.
Frontiers in Cellular and Infection Microbiology|September 24, 2024
Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma <i>in situ</i>-population-based follow-up of two cluster-randomized trialsMatti Lehtinen, Penelope Gray, Tapio Luostarinen, et al.
Pageof 4